Trending News
News
News
Drug Delivery Systems Improved by Lipid Nanoparticles
Structural biologists and pharmaceutical scientists have teamed up to improve the drug delivery system made famous by the COVID-19 vaccines.
News
“Exciting” New Alzheimer’s Drug Slows Disease Progression, But Side Effects Dampen Celebrations
A paper outlining the efficacy of a new drug for Alzheimer’s disease has been published. The hotly awaited findings confirm that the compound, donanemab, can delay the rate of decline in individuals with early-stage Alzheimer’s by 22.3%. Nevertheless, side effects complicate the picture.
News
Generic Ketamine Performs Strongly in Depression Trial
Around 20% of participants achieved total remission from their symptoms of severe depression after a month of bi-weekly injections with a low-cost version of ketamine.
News
Atypical Chronic Sinusitis Explored
Scientists explored treatment refractory forms of chronic sinusitis with unclear etiology, where in many cases only symptom control can be achieved, noting that these cases require interdisciplinary diagnostics and treatment.
News
Cell Therapy Shows Promise for Patients With Relapsed Leukemia
A single infusion of chimeric antigen receptor T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial.
News
Existing Drug Could Help Overcome Breast Cancer Resistance
An already approved drug could help eliminate resistance to the most effective treatment against metastatic breast cancer.
News
Long COVID Risk Reduced by Common Diabetes Drug
Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study.
News
AI Aids Drug Discovery for Lyosomal Storage Disease
Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers to better understand a serious metabolic disease.
News
FDA Approves First Non-Prescription Daily Oral Contraceptive
The first daily oral contraceptive pill – Opill® (norgestrel) – has been approved for use by the U.S. Food and Drug Administration without the need for a prescription, meaning it could soon be available at drugstores, grocery stores and online.
News
Skin-Lightening Agents – What Users Don’t Know Could Hurt Them
Researchers from Northwestern University have conducted a study to explore skin-lightening habits among skin of color (SOC) individuals in the United States. The study suggests a lack of awareness exists about the potential dangers associated with this practice.
Advertisement